Cargando…
A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
Autores principales: | Olivet, Julien, Maseko, Sibusiso B., Volkov, Alexander N., Salehi-Ashtiani, Kourosh, Das, Kalyan, Calderwood, Michael A., Twizere, Jean-Claude, Gorgulla, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884476/ https://www.ncbi.nlm.nih.gov/pubmed/35231394 http://dx.doi.org/10.1016/j.ymthe.2022.02.015 |
Ejemplares similares
-
Screening Drugs for Broad-Spectrum, Host-Directed Antiviral Activity: Lessons from the Development of Probenecid for COVID-19
por: Tripp, Ralph A., et al.
Publicado: (2023) -
Thapsigargin: key to new host-directed coronavirus antivirals?
por: Shaban, Mohammed Samer, et al.
Publicado: (2022) -
Broad-Spectrum Antiviral Therapeutics
por: Rider, Todd H., et al.
Publicado: (2011) -
Broad-spectrum antiviral agents
por: Zhu, Jun-Da, et al.
Publicado: (2015) -
Broad-Spectrum Antivirals and Antiviral Drug Combinations
por: Oksenych, Valentyn, et al.
Publicado: (2022)